Follow-up status and survival according to WHO diagnosis of patients in the Vienna series compared with the historical cohort from Cologne
| . | Vienna . | Cologne . |
|---|---|---|
| ET | ||
| Follow-up, y (median) | 7.3 | 9.5 |
| Person-years | 1162 | 1621 |
| Censored patients, % | 83 | 73 |
| Survival, y* | 21.2 | 16.1 |
| 95% CI | 19.1-23.3 | 14.6-17.4 |
| Early PMF | ||
| Follow-up, y (median) | 6.9 | 7.0 |
| Person-years | 565 | 3,932 |
| Censored patients, % | 68 | 56 |
| Survival, y* | 14.4 | 10.8 |
| 95% CI | 11.8-17.0 | 9.4-12.2 |
| . | Vienna . | Cologne . |
|---|---|---|
| ET | ||
| Follow-up, y (median) | 7.3 | 9.5 |
| Person-years | 1162 | 1621 |
| Censored patients, % | 83 | 73 |
| Survival, y* | 21.2 | 16.1 |
| 95% CI | 19.1-23.3 | 14.6-17.4 |
| Early PMF | ||
| Follow-up, y (median) | 6.9 | 7.0 |
| Person-years | 565 | 3,932 |
| Censored patients, % | 68 | 56 |
| Survival, y* | 14.4 | 10.8 |
| 95% CI | 11.8-17.0 | 9.4-12.2 |
Estimated mean survival.